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Abstract
Bone fractures, where the innate regenerative bone response is compromised, represent between 4 and 8 hundred thousands of the
total fracture cases, just in the United States. Bone tissue engineering (TE) brought the notion that, in cases such as those, it was prefer-
able to boost the healing process of bone tissue instead of just adding artificial parts that could never properly replace the native tissue.
However, despite the hype, bone TE so far could not live up to its promises and new bottom-up approaches are needed. The study of
the cellular interactions between the cells relevant for bone biology can be of essential importance to that. In living bone, cells are in a
context where communication with adjacent cells is almost permanent. Many fundamental works have been addressing these commu-
nications nonetheless, in a bone TE approach, the 3D perspective, being part of the microenvironment of a bone cell, is as crucial. Works
combining the study of cell-to-cell interactions in a 3D environment are not as many as expected. Therefore, the bone TE field should
not only gain knowledge from the field of fundamental Biology but also contribute for further understanding the biology of bone. In this
review, a summary of the main works in the field of bone TE, aiming at studying cellular interactions in a 3D environment, and how they
contributed towards the development of a functional engineered bone tissue, is presented.
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Introduction
Bone tissue is a highly specialized tissue that has as main function
the structural support of the body. Moreover, it also functions as a
mineral reservoir of the body, a protection for the internal organs
and is involved in motion and load bearing. Taking in account the
functional importance of this tissue, one may infer that any bone
injury poses a high impact on the quality of life of an individual. In
the United States alone, there are about 8 million bone frac-
tures/year of which 5–10% represent cases of healing delay or
non-union fractures [1, 2] that require the enhancement of the
bone tissue innate regenerative capacity. In order to tackle these
issues, tissue engineering (TE) presents itself as a phenomenal
tool. TE has been defined [3] as an interdisciplinary area that com-
bines the knowledge of the engineering and life sciences fields for
the creation of functional constructs that improve, maintain or
restore the function of a given tissue. The current TE paradigm
encompasses the application of three basic elements: appropriate
cells, a 3D polymeric matrix that supports cell growth, and growth
factors that provide cells an adequate chemical environment [4,
5]. Nonetheless, in order to apply these principles to such a spe-
cial tissue like bone it is imperative to be sensitive to bone biology
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aiming at understanding how its correct function is achieved.
Clearly, fundamental in this process is to recognize the complex
biochemical environment that surrounds cells in bone tissue and
within which cellular interactions play a pivotal role. This review
focuses on the importance of cell-to-cell interactions in the con-
text of bone tissue engineering first by looking at basic bone biol-
ogy and then at what has been done to study those interactions.
Finally, several co-culture models are analysed in the frame of the
different strategies used in bone TE.
Bone biology
In the adult skeleton, bone tissue presents two different architec-
tural forms: the trabecular bone [6–9], with 50–90% porosity, rep-
resents approximately 20% of the skeleton and can be found in the
metaphysys of long bones and in vertebral bodies; and the corti-
cal bone [6–9], an almost solid form of bone with a low porosity
that represents 80% of the skeleton.
Osteoblasts, osteocytes and osteoclasts are the three main cell
types that can be found in bone tissue, having each one of these
defined functions crucial for bone homeostasis [10–14].
Osteoblasts, anchorage-dependent cells, are highly responsive to
mechanical and chemical stimulus that are relayed through multi-
ple cell-to-matrix and cell-to-cell interactions [15, 16]. These
interactions are mediated through specific receptors and trans-
membranous proteins such as integrins, cadherins and connexins
leading to bone’s extracellular matrix production and mineraliza-
tion [15–19]. As matrix is deposited and calcified, some
osteoblasts become entrapped in it and achieve their fully differ-
entiated state, becoming osteocytes. These are the most abundant
cells in bone. They are smaller and rounder than osteoblasts and
present a high number of filopodia that permit homotypic connec-
tions as well as interactions with bone-linning osteoblastic cells.
These connections form a 3D network that is believed [13, 20, 21]
to function as a mechanical stimuli transduction system and as a
general regulator of bone homeostasis. Nonetheless, osteoclasts
are also seen as critical players in this regulatory process. They
are multinucleated and highly specialized cells, derived from the
haematopoietic lineage, that have the function of resorbing bone
by creating a tight seal resorption pit at the bone surface [22–24].
In these pits, osteoclasts create an acidic environment and secrete
lytic enzymes that become activated at low pH.
The exact mechanisms involved in bone homeostasis are still
far from being well understood; however, two routes are currently
accepted to be responsible for skeletal formation and mainte-
nance: bone modelling and bone remodelling [25–27]. The modu-
lation of skeleton geometry during growth, in order to reach the
optimal geometry to fulfil the requirements of bone function, is
referred to as bone modelling [25–27]. This process progresses
by selective bone resorption or formation at specific sites.
Osteoclastic activity is regulated independently of osteoblastic
activity, i.e. bone formation never occurs where bone is being
resorbed [25–27]. In opposition, in bone remodelling [25–27],
osteoclastic activity is strictly coupled with osteoblastic activity.
Bone forming and bone resorbing activities occur in a coordinated
manner, so that the amount of produced bone balances the
amount of resorbed bone [27]. This coupling of bone formation
and bone resorption is spatially enclosed within specialized
anatomic structures called basic multicellular units (BMUs)
[27–30]. These temporary structures, mainly formed by
osteoblasts and osteoclasts, exert their action in three sequential
phases that, overall, constitute a bone remodelling cycle: activa-
tion (of remodelling activity in the target area), resorption and for-
mation [27–30]. It is currently accepted [27, 29, 30] that BMUs
progress through the bone in a 3D way, forming tunnels in the
cortical bone or trenches in the trabecular bone. Spatial control of
the BMUs, in terms of target area selection and movement, is
thought to be controlled by the osteocytes [27, 29, 30] since the
sensitivity of these cells to mechanical stimulus in bone tissue, as
well as their organization in a network represent significant prop-
erties for the perfect conduction of the bone remodelling process
[27, 29, 30]. Bone vasculature is also decisive in the remodelling
process. In addition to the demonstration of an intimate relation
between new blood vessels and osteogenesis [31–33], it was
already proved that every BMU is located in the vicinity of a blood
vessel [34], which grows at the same rate the BMU advances [34,
35]. These facts indicate the crucial role of vasculature in bone
remodelling and consequently the importance of vascular cells
such as endothelial cells and pericytes. The most likely role of
blood vessels as a source of biochemical signals and cells, and as
a major player in the coupling of bone resorption and formation
during bone remodelling is explored elsewhere [36].
The relevance of cell–cell interactions
in bone tissue engineering
Taking in consideration the biology of bone tissue, it is quite clear
that the understanding of the cellular interactions that regulate the
homeostasis and regeneration of this remarkable tissue is essen-
tial to a successful TE strategy. The study of these cellular interac-
tions in vitro relies on co-culture systems, a tremendously useful
methodology where two or more cell types are cultured at the
same time. It increases the complexity of typical cell culture sys-
tems, allowing the in vitro settings to closely mimic the in vivo
environment. 2D co-culture systems have been extensively used
by cell biologists to study cell interactions as an attempt to 
understand specific cellular mechanisms and pathways. In this
part of this review, the importance of cell-to-cell interactions and
how these are studied in the bone TE field are discussed and 
summarized in Fig. 1.
The self-renewal and multilineage differentiation abilities of
stem cells (SCs) render these cells as the potential ultimate
source of cells to create tissue-like constructs for TE, including
bone TE. Subsequently, several studies [37–43] regarding cellular
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interactions relevant for bone TE involve, in addition to osteoblasts,
different populations of SCs obtained from various origins and
species. However, these studies have been performed mainly to
assess the differentiation potential of SCs towards the osteogenic
lineage by establishing several co-culture systems. Mature cells
like chondrocytes [37–39], macrophages [40], endothelial cells
[42] or myeloma cells [41] have all been proven to promote the
osteogenic differentiation of mesenchymal SCs (MSCs), either by
direct or indirect interactions. Co-culture with osteoblasts was
also reported as a method to direct the differentiation of embry-
onic stem cells (ESCs), either from mouse or human origin, into
the osteogenic lineage [44, 45]. However, a major issue that many
tissue engineers fail to address is the atypical osteoblastic func-
tion of osteoblastic cells in culture when compared with
osteoblasts in vivo. This is reflected on the quality of bone formed
by osteoblasts in vitro [46–48], either in a 3D or a 2D environ-
ment, which is undoubtedly a major drawback when envisaging a
possible clinical application.
Another very important issue that greatly affects the perform-
ance of a TE construct is the vascularization issue since an insuf-
ficient blood supply in implanted engineered tissues will deter-
mine their failure [49–52]. Vascularization is regarded as essential
in TE in general and in bone TE in particular [53, 54]. In the usual
bone TE strategy, where bone cells are seeded and cultured in
scaffolds before implantation, a recurrent find points out to cell
death at the bulk of the scaffold by hypoxia [49, 50, 55]. It became
clear that the production of a vascular network that could perfuse
the engineered constructs is essential. So far, the proposed solu-
tion relies on the creation of a blood vessel network within an
engineered tissue prior to transplantation by incorporating cells
that will lead to blood vessel formation within the scaffold matrix
[56–59] and subsequent engraftment with the host tissue.
Moreover, the extent of knowledge regarding the interactions
between endothelial cells and bone forming or osteoprogenitor
cells indicates the existence of reciprocal interactions between
both types of cells that are essential to their normal function
[60–69]. It is therefore logical that the interaction of endothelial
cells and osteogenic or osteoprogenitor cells is a critical issue to
be explored by bone tissue engineers.
As described in the previous section, bone modelling and
remodelling processes rely in the specific crosstalk between
osteoblasts and osteoclasts. It is, for example, well established
that osteoblasts are deeply involved in the formation of osteo-
clasts as well as in their correct functioning [47, 70–74] but the
effects of osteoclasts over osteoblastic function are still poorly
understood. Studies done with osteoclast-deficient mice models
have shown not only a lack of bone resorption activity but also
deficient osteoblastic activity, which is reflected in the quality of
the formed bone [75, 76]. Dai et al. [75] showed that implanting
bone buds from osteoclast deficient mice into wild type mice
resulted in the recovery of the buds’ normal development. This
work presents a major indication that engineering bone tissue for
clinical use may require the use of osteoclasts along with
osteoblasts. Therefore, compelling evidence suggests that osteo-
clasts have functions, namely regulatory functions, other than just
bone resorption, which is reviewed elsewhere [77]. Additionally,
the vital importance of cell-to-cell interactions for bone homeosta-
sis has been also reinforced by other works. Indications regarding
the production of pro-osteogenic factors by osteoclasts were
given in a study that proved that osteoclast-conditioned medium
induced bone nodule formation by murine MC-3T3-E1 pre-
osteoblasts [78]. Increasing attention has also been given to the
signalling action between ephrinB2 cell surface protein, present
in osteoclasts, and its receptor EphB4, present in osteoblasts [79].
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Fig. 1 Positive (!) and nega-
tive (–) effects of cell-to-cell
interactions between different
cell types relevant in bone biol-
ogy. Cell differentiation, func-
tion and proliferation were the
reviewed parameters.
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It was shown that ephrinB2-EphB4 signalling is bidirectional and
links two key molecular mechanisms of differentiation, one
osteogenic and the other osteoclastogenic [79]. This is of major
importance since it describes a mechanism where both cells influ-
ence the differentiation of one another, possibly in simultaneous,
by cell–cell contact.
Additional cues to create a successful bone TE construct might
be provided by the endochondral ossification process in which
chondrocytes produce a cartilagineous anlage that is mineralized
by osteoblasts and osteocytes later in the process. A logic analy-
sis would consider the high probability of chemical factors that
enhance osteogenic activity and mineralization being produced by
chondrocytes. Nonetheless, a study by Jiang et al. [80] shows that
in spite of an increase in alkaline phosphatase (ALP) activity in
osteoblasts co-cultured with chondrocytes, their mineralization
ability was diminished when compared to controls. This negative
effect seemed however restricted to fully differentiated
osteoblasts, which is in accordance with other works in the litera-
ture that describe chondrocytes as having a positive effect on the
osteogenic differentiation of MSCs [37–39]. Thus, in a bone TE
strategy based on the use of chondrocytes, it may be beneficial to
use MSCs or other osteoblastic precursors instead of fully differ-
entiated osteoblasts.
Therefore, creative ways to ensure the clinical success of engi-
neered constructs are needed. The study of the interactions
between cell types relevant for bone TE is a powerful tool in the
design of tissue-engineered bone constructs. But how is this
knowledge applied by bone tissue engineers?
Co-culture models in bone tissue 
engineering
Angiogenesis
As mentioned before, vascularization is a critical issue for TE con-
structs aiming at regenerating tissues. It has been demonstrated
that the in vivo implantation of a cellularized construct without the
production of an adequate vascular network leads to cell necrosis
in the bulk of the construct [49–52]. Models such as the arteriove-
nous loop (AVL) model [81–83] propose a very good strategy to
overcome this problem. In this model, an AVL is inserted in an iso-
lation chamber together with a scaffold or matrix adequate for
bone TE with the objective to induce vascularization in the latter
[83]. Using this model, Arkudas and colleagues [82] injected rat
osteoblasts into non-vascularized processed bovine cancellous
bone (PBCB) matrices and into similar matrices that were prevas-
cularized using the AVL method. Both matrices were then
implanted sub-cutaneously in rats. The prevascularized show by
far the best results in terms of osteoblasts survival and expression
of osteogenic genes, thus stressing the importance of the vascu-
larization issue in bone TE.
3D co-cultures established in scaffolds have been proposed by
tissue engineers as a powerful tool to overcome this question [56,
84–95]. Two works reported that co-culturing endothelial cells
with human bone marrow MSCs (hBMSCs) in poly-lactic-glycolic
acid (PLGA) scaffolds increased bone formation after implantation
in a critical size rat calvarial defect compared to implanted scaf-
folds only seeded with hBMSC [94, 95]. These studies emerged as
a proof-of-concept that co-culturing endothelial cells with
osteogenic or osteogenic progenitor cells in a 3D scaffold can be
an adequate strategy for targeting the vascularization of tissue-
engineered bone. Several other works [56, 84–95] have been
reporting the co-cultivation of endothelial cells with osteogenic or
osteoprogenitor cells for bone TE purposes. Rouwkema et al. [87]
showed that co-culturing human umbilical vein endothelial cells
(HUVECs) with hMSCs in a spheroid aggregate model up-regu-
lated ALP expression of the hMSCs in comparison with monocul-
tured spheroids. On the other hand, Kyriakidou et al. [91] found
that co-culturing HUVECs with a human osteoblast-like cell line,
MG-63, in porous poly("-caprolactone) (PCL) scaffolds under
dynamic conditions favoured the proliferation of both types of
cells but not their function. ALP activity and ECM production of the
osteoblast-like cells did not show a significant enhancement in
comparison to the controls. More interestingly, Yu et al. [92, 93]
reinforced the potential of osteoblast/endothelial cell 3D co-cul-
tures for bone tissue engineering purposes. ECs and osteoblasts
differentiated from the bone marrow of BALB/c mice were co-cul-
tured in hydroxyapatite-PCL (HA-PCL) scaffolds and implanted in
a critical size bone defect in the femur of mice of the same strain
[93]. The authors observed a dramatic increase in vascularization
and bone formation in the co-culture groups in comparison with
scaffolds only seeded with osteoblasts. In addition, necrosis was
found to occur in the osteoblasts groups but not in the co-culture
groups. Similar results were found by the same group in a work
that was carried out under the same conditions but in rats [92].
Besides the enhanced bone formation and vascularization without
signs of necrosis, the co-culture grafts presented better mechani-
cal properties than those only seeded with osteoblasts.
A significant effort has also been applied to understand the
effect of osteogenic or osteoprogenitor cells on the angiogenic
potential of endothelial cells. Wenger et al. [90] established a 3D
collagen-based co-culture system of HUVECs and human
osteoblasts (hOB). In this model, cells were grown in spheroid
aggregates (the result of cell’s self-aggregation in non-adhering
conditions), either homogeneous, only with HUVECs, or heteroge-
neous, HUVECs plus hOB, and then embedded in collagen gels. It
was verified that the presence of osteoblasts within the heteroge-
neous aggregates, diminished the formation of sprouts under
angiogenic stimulus as compared with homogeneous spheroids
suggesting an inhibitory effect of osteoblasts over endothelial
cells activity. In contrast, Rouwkema et al. [87] developed a sphe-
roid model where HUVECs were cultured with hMSCs. In this
case, HUVECs were capable of forming a pre-vascular network
that was further developed after in vivo subcutaneous implanta-
tion in nude mice. Using polyurethane (PU) cylindrical scaffolds,
Hofmann et al. [85] performed in vitro co-cultures of HUVEC and
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hOB, having platelet-released growth factors (PRGF) as the only
supplementation of the culture medium. Osteoblasts-seeded scaf-
folds were found to support cell proliferation and vessel formation
by HUVECs in contrast with scaffolds loaded only with HUVECs.
The contradictory results of some of these works suggest that this
strategy is highly dependent on culture conditions such as cell
seeding density, 2D or 3D culture and differentiation state of
osteogenic cells.
The origin of endothelial cells appears also as an important
issue. Stahl et al. [88] established a co-culture model similar to
Wenger et al. [90] but of HUVECs and human umbilical cord blood
endothelial progenitor cells (EPCs) and primary osteoblasts. The
authors verified that osteoblasts inhibited the sprouting of
HUVECs but not of EPCs. Similar results were reported in works
that established co-cultures of human primary osteoblasts and
HUVECs, human outgrowth endothelial cells (hOECs) and human
dermal microvascular endothelial cells (hDMECs) in 2D condi-
tions, 3D aggregates and 3D scaffolds [84, 89]. hDMECs were cul-
tured in the presence and absence of hOB on porous discs of three
different materials, beta-tricalcium phosphate (beta-TCP), HA,
nickel-titanium (NiTi) and, additionally, on silk fibroin nets [89].
For all the materials, hDMECs only formed microcapillary-like
structures in the presence of osteoblasts, independently of the
angiogenic supplementation. When hOECs and HUVECs were cul-
tured with and without osteoblasts either in 2D conditions or in a
3D spheroid aggregate co-culture model, a pre-vascular network
was only formed by hOECs and in the presence of osteoblasts
[84]. In accordance, Santos et al. [56] co-cultured hDMECs with
primary human osteoblasts in starch-poly(3-caprolactone) (SPCL)
fibre mesh scaffolds. Results showed that hDMECs self-assem-
bled in a microcapilary-like structure (Fig. 2), with a lumen where
cells where positive for collagen IV, a marker of endothelial base-
ment membrane (Fig. 3). No such results were encountered in the
control groups where hDMECs were cultured alone. Moreover,
osteoblasts were found to produce more VEGF and their collagen
I mRNA levels were significantly higher when in co-culture. This is
a proof of osteoblast-endothelial cell bi-directional communica-
tion. Reinforcing this, similar results were reported [86] when hOB
were co-cultured with hOEC in SPCL scaffolds and then subcuta-
neously implanted in SCID mice. The constructs with both types
of cells revealed improved vascularization in comparison with
constructs only seeded with hOEC. Thus, these works have proven
that osteoblasts provide endothelial cells sufficient stimuli for
them to form a network of micro-vessel like structures. More
importantly, in some cases, the formation of that network was
achieved without the addition of angiogenic factors to the culture
medium [89]. This is probably the best demonstration on how 
co-cultures provide a higher complexity culture system, with self-
regulation, that can be of much use in TE approaches.
Overall, these approaches represent the growing awareness of
bone tissue engineers to the significance of working on the vascu-
larization issue prior to bone tissue formation, which is a natural
evolution taking in account the (lack of) results delivered by typi-
cal TE approaches so far.
Osteochondral strategies
There are conditions where cartilage defects progress to the
underlying sub-chondral bone, affecting, at the same time, bone
and cartilage tissues [96]. In these cases, the application of osteo-
chondral TE constructs is seen as a valid solution to regenerate
both bone and cartilage tissues [97, 98]. To date, the proposed
osteochondral TE constructs consist on co-culturing osteogenic
and chondrogenic cells in 3D supports [99–101]. However, there
are few works in the literature using osteochondral constructs that
address bone formation, focusing most of them instead on the
cartilage part.
Spalazzi et al. [101] studied the interactions between bovine
osteoblasts and chondrocytes in poly-lactide-co-glycolide and
bioactive glass (PLGA-BG) composite scaffolds and films. The
authors observed that in comparison with control groups, only
seeded with osteoblasts or chondrocytes, co-cultured constructs
enhanced the ability of chondrocytes to maintain their normal
morphology for a longer time period. The presence of osteoblasts
and respective layered matrix also increased chondrocyte prolifer-
ation and matrix production. Similar results were observed by
Mahmoudifar et al. [100] after co-culturing, under dynamic condi-
tions, human foetal chondrocytes and osteoblasts in PLGA scaf-
folds. The presence of osteoblasts was found to improve cartilage
formation in terms of glycosaminoglycans (GAG) content and total
© 2009 The Authors
Journal compilation © 2010 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Fig. 2 Distribution and organization of hDMECs and hOBs in co-culture
on SPCL fibre mesh scaffolds after 35 days of culture. In order to distin-
guish between the two cell populations, samples were stained for
PECAM-1(CD31; green fluorescence, endothelial-specific) and nuclei
(blue fluorescence, both hOBs and hDMECs). (This picture is a kind gift
of Marina I. Santos.)
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collagen deposition in comparison with no osteoblasts-containing
controls. In contrast, the authors did not find significant benefit, in
terms of cartilage formation, in co-culturing the chondrocytes with
either bone chips or cartilage chips as possible sources of growth
factors. Although the authors acknowledge that mineralization
occurred in the osteoblast seeded part of the scaffold, no further
analysis, like for the work by Spalazzi et al. [101], were performed
concerning the osteogenic performance of the construct. The
effect of chondrocytes over osteogenic cells in an osteochondral
construct was explored in a work by Cao et al. [99]. Human
osteogenic cells, previously differentiated form stromal cells of the
iliac crest, were co-cultured with human chondrocytes, obtained
from the rib cartilage, in PCL scaffolds. The presence of chondro-
genic cells had a positive effect on the production of the early
osteogenic marker ALP but a negative effect on the expression of
the later marker, osteocalcin. Nevertheless, the mineralization of
the osteochondral construct was supported by the osteogenic
cells. In contrast, Jiang et al. [80] reported that culturing bovine
chondrocytes and osteoblasts in micromass culture had a nega-
tive effect both on the chondrocyte and osteoblastic phenotype.
Moreover, mineralization in the co-cultures was significantly
diminished in comparison with monoculture controls.
These results demonstrate that chondrocytes and osteoblasts
can modulate both cell types’ phenotype in tissue-engineered con-
structs. However, how will tissue engineers manipulate these
interactions, either by controlling the culture conditions or the 3D
scaffold, in order to obtain suitable osteochondral contructs, is
still to be seen.
Macrophages, monocytes and osteoclasts
Macrophages, which are key players in an inflammatory process
within the periprosthetic milieu, produce several cytokines and
other soluble factors that affect all the other neighbouring cells
[102–104] and have been often associated with implant failure. In
this sense, co-cultures of monocytes and macrophages, with
osteoblasts have been used in the biomaterial field as a way to elu-
cidate the macrophages biological response to orthopaedic bio-
materials particulates in a more complex system that includes
bone-forming cells, osteoblasts [105–107]. The translation of the
results from these works into the TE field is scarce; however, 
co-culturing monocytes/macrophages or monocyte/macrophages-
derived osteoclasts and bone cells in 3D biodegradable matrices
might be an interesting approach towards engineering high-quality
bone [47]. Bone tissue engineers have not explored much this
approach, existing therefore few works [108, 109] that co-
cultured monocytes and stromal cells in 3D scaffolds. Domaschke
et al. [108] studied the in vitro remodelling of mineralized collagen I
scaffolds using co-cultures of ST-2, a mouse bone marrow stromal
cell line, and human monocytes. In this work, it was demonstrated
that the co-cultures induced both osteoclastogenesis and
osteoblastogenesis from progenitor cells of both lineages in a
process, according to the authors, comparable to bone remodel-
ling that involved the resorbing of the scaffold by the osteoclasts
and matrix mineralization by the osteoblasts.
It seems obvious that exploring this model that focuses on the
balance between the degradative osteoclastic and the constructive
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Fig. 3 Collagen IV immuno-
histochemical staining of thin-
section of hDMECs and hOBs
in co-culture on SPCL fibre
meshes after 35 days of 
culture. Nuclei were counter-
stained with Mayer’s haema-
toxylin. ‘*’ identifies the scaffold
material. (This figure is a kind
gift of Marina I. Santos.)
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osteoblastic activities, as well as co-culturing mono-
cytes/macrophages and bone cells to highlight the initial bone
healing mechanisms, may be of extreme use for developing suc-
cessful bone tissue engineering strategies.
Stem cells
Nowadays, SCs, which are capable of differentiate into the most
varied lineages of cells, are seen as an exceptionally promising
tool in TE. In bone TE, there has been the tendency to differenti-
ate those cells into the osteogenic lineage using exogenous 
factors, before scaffold seeding, probably due to time and cost
efficiency. Nonetheless, SCs differentiation can be also directed
towards the osteogenic lineage in situ using co-culture systems
in a 3D environment. Kim et al. [110] showed that human ESCs
committed to the osteogenic lineage by co-culture with primary
cells from bone explants and seeded in poly(D,L-lactic-co-
glycolic acid)/hydroxyapatite composite scaffolds were able to
support new bone formation in an immunodeficient mouse
model. Although not presenting the controls with hESCs not sub-
jected to co-culture with the bone primary cells, this work
demonstrates the potential of the use of co-cultures to direct the
fate of SCs. There is no doubt that using 3D co-cultures to induce
the differentiation of SCs towards the osteogenic lineage will be a
potentially successful path for future bone tissue engineers.
Future directions
The study of cellular interactions can provide not only the under-
standing of the major drawbacks that tamper bone TE evolution
but also the solution to overcome those obstacles. The jump from
2D cultures to 3D cultures in the TE field was an acknowledgement
that culture systems needed to emulate more closely in vivo sys-
tems. In fact, it was suggested that many of the lessons brought
by 3D research in TE could be adopted to other field such as can-
cer research [111].
To manipulate cellular function through the use of co-cultures
is nothing less than trying to mimick what happens in vivo. As this
is one of the precepts of TE it should be largely embraced by tis-
sue engineers. Combining co-cultures with 3D culture is the way
to achieve higher complexity models of superior quality.
Nonetheless, the major hurdle in bone TE is and will continue
to be the vascularization issue. The question ‘OSTEOGENESIS
AND THE VASCULATURE: SHOULD THE SCAFFOLD COME
FIRST?’ as presented by Mikos et al. [57] makes more sense
than ever. The tendency in the next few years will be to make
endothelial cells an indispensable component of any bone TE
strategy though osteoblasts or osteoprogenitor cells will con-
tinue to be essential. Perhaps the default strategy in the future
will be to co-culture, in a 3D scaffold, endothelial and
osteogenic cells. Either way, co-cultures will continue to be an
essential tool in basic research but if it will be so in applied
research, only time will tell.
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